PER

21K posts

PER banner
PER

PER

@gotoPER

Advancing #healthcare through continuing medical education live and online experiences in #oncology, #psychiatry, #cardiology, and so much more.

Greater New York Area Katılım Mayıs 2009
3.1K Takip Edilen7.8K Takipçiler
Sabitlenmiş Tweet
PER
PER@gotoPER·
Education doesn’t stop. And neither do we. 2026 is all about: 🌎Global conversations 📍Iconic destinations 💡Real-world impact Together, we can turn collective knowledge into clinical impact, redefining the standard of patient care. Be part of it at gotoPER.com.
English
0
2
3
1.2K
PER retweetledi
Mazyar Shadman, MD MPH
Excited to kick off our inaugural “Fred Hutch and Friends” meeting! Outstanding participation from both academic and community oncology practices. This year’s theme is Immunotherapy, with the goal of bringing academic and community partners together to advance collaboration, education, and patient care. @fredhutch #FredHutchandFriends @gotoPER @PGrivasMDPhD
Mazyar Shadman, MD MPH tweet mediaMazyar Shadman, MD MPH tweet mediaMazyar Shadman, MD MPH tweet mediaMazyar Shadman, MD MPH tweet media
English
0
3
11
1.5K
PER
PER@gotoPER·
Bispecific Antibodies In Lymphoma and Multiple Myeloma: Operational Lessons and Collaborative Strategies (Spotlight CE Session) x.com/i/broadcasts/1…
English
0
0
0
99
PER
PER@gotoPER·
PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence x.com/i/broadcasts/1…
English
0
0
0
72
PER
PER@gotoPER·
Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer (1) (1) x.com/i/broadcasts/1…
English
0
1
0
112
PER
PER@gotoPER·
Applying the Latest Evidence for New Targeted Therapies in HER2-Positive GEA x.com/i/broadcasts/1…
English
0
0
0
55
PER
PER@gotoPER·
🌍PER Global Perspectives: Optimizing NSCLC Readiness in the Era of TROP2-Targeted ADCs, a 3-part webinar series on frontline combinations, CNS disease, & toxicity differentiation. Gain insights from global experts shaping the future of NSCLC. Register now tinyurl.com/28vdwy7z
PER tweet mediaPER tweet mediaPER tweet mediaPER tweet media
English
0
0
1
93
PER
PER@gotoPER·
Windy City Wednesday with PER® 🚨 The landscape of ADCs and bispecific antibodies across solid tumors is rapidly expanding—are you ready to navigate the latest targets, data, and clinical decisions? Join us to learn more! #gotoPER #windycitywednesday #ASCO26
PER tweet mediaPER tweet media
English
0
0
0
151
PER
PER@gotoPER·
Stay current on the mTNBC frontline treatment landscape with the @OncBrothers. Review pivotal frontline trial data, explore how PD-L1 status can guide treatment decisions, and gain practical strategies for managing treatment-related adverse events. 👉bit.ly/4tv6Hed
English
0
0
3
147
PER
PER@gotoPER·
Behind every outcome, there’s a nurse. 💛 This #NationalNursesWeek, we recognize the nurses who are there at every step of care. Their work shapes outcomes, experiences, and hope for patients and families. Thank you, nurses, for everything you make possible. #OncologyNursing
PER tweet media
English
0
0
0
96
PER
PER@gotoPER·
Unlock the latest insights on KRAS as a Therapeutic Target in PDAC. Explore efficacy & safety data, learn how to apply molecular profiling results, evolving evidence, and patient-specific factors to optimize targeted treatment. Start learning now: bit.ly/4nhLlPX
English
0
0
0
104
PER
PER@gotoPER·
This World Ovarian Cancer Day, we stand together to raise awareness, inspire action, and advance care for every patient affected. Join Co-Chair Ritu Salani, MD, MBA at the 17th Annual International Symposium on Gynecologic Malignancies tomorrow! #WorldOvarianCancerDay #IOG #CME
English
0
0
0
94
PER
PER@gotoPER·
Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer (1) x.com/i/broadcasts/1…
English
0
0
0
61
PER
PER@gotoPER·
Windy City Wednesday with PER! Join these expert-led sessions highlighting key advances shaping today’s breast cancer landscape and gain deeper insight into emerging clinical trial data that is driving practice-changing decisions. #gotoPER #windycitywednesday #ASCO26
PER tweet mediaPER tweet mediaPER tweet media
English
0
0
0
104